| scholarly article | Q13442814 |
| P356 | DOI | 10.1139/CJPP-2016-0158 |
| P698 | PubMed publication ID | 28249117 |
| P2093 | author name string | Bassant M Barakat | |
| Hala M F Mohammad | |||
| Amany Y Elkazaz | |||
| Angie M Ameen | |||
| P2860 | cites work | Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease | Q24794457 |
| Pesticides and Parkinson's disease--is there a link? | Q25257240 | ||
| Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease | Q28196448 | ||
| Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease | Q28199468 | ||
| Chronic ketamine administration modulates midbrain dopamine system in mice | Q28482530 | ||
| Chronic systemic pesticide exposure reproduces features of Parkinson's disease | Q29614763 | ||
| A highly reproducible rotenone model of Parkinson's disease | Q30490799 | ||
| Discovery of cyclooxygenase inhibitors from medicinal plants used to treat inflammation. | Q33814940 | ||
| Acetyl-11-keto-β-boswellic acid (AKBA); targeting oral cavity pathogens | Q34047219 | ||
| Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives | Q34426072 | ||
| Neuroprotection by acetyl-11-keto-β-Boswellic acid, in ischemic brain injury involves the Nrf2/HO-1 defense pathway | Q34485583 | ||
| Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease. | Q34547466 | ||
| The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration. | Q34786812 | ||
| Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells | Q35546425 | ||
| Inflammation and neurodegeneration in Parkinson's disease | Q35756452 | ||
| Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration | Q35838968 | ||
| Interleukin-6 May Contribute to Mortality in Parkinson's Disease Patients: A 4-Year Prospective Study | Q36006272 | ||
| Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders | Q36161821 | ||
| Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family | Q36435782 | ||
| Short-Term Treatment with Silymarin Improved 6-OHDA-Induced Catalepsy and Motor Imbalance in Hemi-Parkisonian Rats. | Q36509484 | ||
| Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease | Q36537780 | ||
| Boswellic acids in chronic inflammatory diseases | Q36616085 | ||
| Common Genetic Variant Association with Altered HLA Expression, Synergy with Pyrethroid Exposure, and Risk for Parkinson's Disease: An Observational and Case-Control Study | Q36858244 | ||
| Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy. | Q37221349 | ||
| Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis | Q37299641 | ||
| The role of inflammation in sporadic and familial Parkinson's disease | Q38105903 | ||
| The synergistic effect of beta-boswellic acid and Nurr1 overexpression on dopaminergic programming of antioxidant glutathione peroxidase-1-expressing murine embryonic stem cells. | Q39313753 | ||
| Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNFalpha, IL-1beta, NO and MAP kinases | Q40166971 | ||
| Boswellic acids inhibit glioma growth: a new treatment option? | Q40757397 | ||
| Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure. | Q41362148 | ||
| Acute and chronic toxicity, cytochrome p450 enzyme inhibition, and HERG channel blockade studies with a polyherbal, ayurvedic formulation for inflammation | Q41999828 | ||
| Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats. | Q42413100 | ||
| Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease | Q43162071 | ||
| Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity | Q43201405 | ||
| Involvement of microtubule integrity in memory impairment caused by colchicine | Q43867233 | ||
| Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. | Q44105707 | ||
| Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats | Q44183832 | ||
| Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich's carcinoma | Q46210824 | ||
| Fluvoxamine alleviates seizure activity and downregulates hippocampal GAP-43 expression in pentylenetetrazole-kindled mice: role of 5-HT3 receptors. | Q46410491 | ||
| Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. | Q46441823 | ||
| Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice. | Q46552275 | ||
| Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion | Q46578960 | ||
| The gastric ulcer protective effect of boswellic acids, a leukotriene inhibitor from Boswellia serrata, in rats | Q46635297 | ||
| Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease | Q46712262 | ||
| Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats | Q46734353 | ||
| Protective effects of nimesulide (COX Inhibitor), AKBA (5-LOX Inhibitor), and their combination in aging-associated abnormalities in mice | Q46782237 | ||
| Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis. | Q46894168 | ||
| Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation | Q47751018 | ||
| Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains | Q48187073 | ||
| The enhancement effect of beta-boswellic acid on hippocampal neurites outgrowth and branching (an in vitro study). | Q48277653 | ||
| Imipramine and amitriptyline ameliorate the rotenone model of Parkinson's disease in rats | Q48646953 | ||
| Acetyl-L-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy. | Q48872124 | ||
| Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. | Q49139320 | ||
| Rotenone induced neurotoxicity in rat brain areas: a histopathological study. | Q52717750 | ||
| Effect of levetiracetam versus gabapentin on peripheral neuropathy and sciatic degeneration in streptozotocin-diabetic mice: Influence on spinal microglia and astrocytes. | Q53228049 | ||
| Complex deregulation and expression of cytokines and mediators of the immune response in Parkinson's disease brain is region dependent. | Q54220006 | ||
| Incensole acetate: a novel neuroprotective agent isolated from Boswellia carterii. | Q55466666 | ||
| P433 | issue | 7 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 819-829 | |
| P577 | publication date | 2017-03-01 | |
| P1433 | published in | Canadian Journal of Physiology and Pharmacology | Q5030248 |
| P1476 | title | Anti-inflammatory and neuroprotective activity of boswellic acids in rotenone parkinsonian rats | |
| P478 | volume | 95 |
| Q92825988 | An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases |
| Q90148604 | Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases |
| Q92339689 | Repeat oral dose safety study of standardized methanolic extract of Boswellia sacra oleo gum resin in rats |
Search more.